Search

everythinglearnresearchcommunity

for

Search:↓

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Alopecia areata involves unique activation of certain immune cells.

Clonally expanded CD8+ T cells cause alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The role of γδT-cells in causing alopecia areata remains unclear.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.